ADMArcher Daniels Midland
Archer-Daniels-Midland Company and its subsidiaries (the "Company" or "ADM") unlocks the power of nature to enrich the quality of life. 10-K, Item 1
- Headquarters
- Chicago, IL
- CEO
- Juan Luciano
- Next results
- around Feb 2, 2027
What changed
10-K filed Feb 17, 2026 against Feb 20, 2025| Area | What changed | Source |
|---|---|---|
| Risk factors | 22 new paragraphs, nothing like them in the previous 10-K | 10-K Item 1A |
| Late filing notice (NT 10-K or NT 10-Q) | NT 10-Q filed 2024-11-12: the company said its 10-Q would be late | 10-K · XBRL |
| Critical audit matters changed | New this year: Investment in Wilmar Impairment Evaluation (“As explained in Notes 1 and 8 to the consolidated financial statements, the Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable, recognizing an impairment loss when a dec”). Same as last year: Animal Nutrition Goodwill Impairment Evaluation | 10-K · XBRL |
| Accounting checks | 9 other checks clear, 2 worth a look | 10-K · XBRL |
| Insiders | 1 open-market buy in the last 90 days | Form 4 |
| Filings | 7 in the last 30 days | EDGAR |
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
What's new, in their words
10-K filed Feb 17, 2026Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-20. Quoted as filed.
As part of its broader strategy, the Company is focused on operational excellence and driving targeted cost reductions. The Company has implemented plans to improve the performance of its manufacturing and production facilities, increase operating leverage within the Nutrition segment, and reduce third party spend and selling, general,…
10-K, Item 1A
Accounting checks
latest 10-K9 of 11 clear 2 worth a look. Checks, not verdicts.
- !Late filing notice (NT 10-K or NT 10-Q)NT 10-Q filed 2024-11-12: the company said its 10-Q would be late
- !Critical audit matters changedNew this year: Investment in Wilmar Impairment Evaluation (“As explained in Notes 1 and 8 to the consolidated financial statements, the Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable, recognizing an impairment loss when a dec”). Same as last year: Animal Nutrition Goodwill Impairment Evaluation
- ✓Receivables -18.5% vs revenue -6.2% (-12.4 pts)
- ✓Cash from operations $5.5B vs net income $1.1B (FY ending 2025-12-31)
- ✓Inventory -10.4% vs revenue -6.2% (-4.2 pts)
- ✓Same auditor in both 10-Ks: Ernst & Young LLP
- ✓No statement of substantial doubt about going concern
- ✓No 8-K item 4.02 in the last 2 years
- ✓No sentence in the 10-K concludes that controls were not effective because of a material weakness
- ✓No 8-K item 2.06 in the last 2 years
- ✓No 8-K item 1.03 in the last 2 years
In the last 30 days
All filings →- Nov 9, 2026Buy McAtee David R II (Director) bought $487K open-market purchase on Feb 5, 2026, reported 9 months late
- Nov 9, 2026Buy McAtee David R II (Director) bought $197K open-market purchase on Nov 5, 2026
- Nov 3, 20268-K Quarterly results 8-K item 2.02
- Nov 3, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
- Oct 31, 2026SEC letter SEC asked 10 questions about Form 10-K for the Year Ended December 31, 2023 letters 2024-05-22 to 2024-12-18 · Segments, Non-GAAP measures, Results discussion (MD&A)
Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q.
RSS feed
Work on ADM in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ADM/export.csv") into a cell.